PL2827843T3 - Sposób wytwarzania dojelitowych alginianowych mikrokapsułek poprzez żelowanie jonowe zawierających diklofenak lub jedną z jego soli oraz zawierającej je wielocząsteczkowej kompozycji farmaceutycznej - Google Patents

Sposób wytwarzania dojelitowych alginianowych mikrokapsułek poprzez żelowanie jonowe zawierających diklofenak lub jedną z jego soli oraz zawierającej je wielocząsteczkowej kompozycji farmaceutycznej

Info

Publication number
PL2827843T3
PL2827843T3 PL12709640.2T PL12709640T PL2827843T3 PL 2827843 T3 PL2827843 T3 PL 2827843T3 PL 12709640 T PL12709640 T PL 12709640T PL 2827843 T3 PL2827843 T3 PL 2827843T3
Authority
PL
Poland
Prior art keywords
salts
pharmaceutical composition
composition containing
via ionic
alginate microcapsules
Prior art date
Application number
PL12709640.2T
Other languages
English (en)
Inventor
Los Mario Atilio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2827843T3 publication Critical patent/PL2827843T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL12709640.2T 2012-03-20 2012-03-20 Sposób wytwarzania dojelitowych alginianowych mikrokapsułek poprzez żelowanie jonowe zawierających diklofenak lub jedną z jego soli oraz zawierającej je wielocząsteczkowej kompozycji farmaceutycznej PL2827843T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/054904 WO2013139377A1 (en) 2012-03-20 2012-03-20 Method for producing enteric alginate microcapsules via ionic gelation containing diclofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them

Publications (1)

Publication Number Publication Date
PL2827843T3 true PL2827843T3 (pl) 2016-11-30

Family

ID=45855800

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12709640.2T PL2827843T3 (pl) 2012-03-20 2012-03-20 Sposób wytwarzania dojelitowych alginianowych mikrokapsułek poprzez żelowanie jonowe zawierających diklofenak lub jedną z jego soli oraz zawierającej je wielocząsteczkowej kompozycji farmaceutycznej

Country Status (15)

Country Link
US (2) US9668978B2 (pl)
EP (1) EP2827843B1 (pl)
CN (1) CN104244927B (pl)
AR (1) AR090187A1 (pl)
BR (1) BR112014023278B1 (pl)
CA (1) CA2899664C (pl)
CL (2) CL2014002465A1 (pl)
ES (1) ES2584403T3 (pl)
MX (1) MX354454B (pl)
PH (1) PH12014501981A1 (pl)
PL (1) PL2827843T3 (pl)
SG (1) SG11201505320TA (pl)
UA (1) UA112345C2 (pl)
WO (1) WO2013139377A1 (pl)
ZA (1) ZA201406886B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3277267B1 (en) 2015-03-31 2021-01-06 Laboratorios Bagó S.A. Enteric-coated pellets containing a proton pump inhibitor
EP3377046A1 (en) * 2015-11-17 2018-09-26 Rontis Hellas S.A. Pharmaceutical composition containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
CN109498571B (zh) * 2018-11-19 2019-09-10 朗天药业(湖北)有限公司 一种艾司奥美拉唑钠缓释微球及其制备方法
TW202126301A (zh) 2019-10-04 2021-07-16 愛爾蘭商席歐拉斯製藥有限公司 小兒懸浮調配物
CN112494450A (zh) * 2020-12-12 2021-03-16 海南海神同洲制药有限公司 化学药专用口腔崩解片包覆结构及其制备方法
CN115317464B (zh) * 2022-09-01 2023-08-08 苏州弘森药业股份有限公司 一种双氯芬酸钾微胶囊及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520119A1 (de) 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
ES2173096T3 (es) 1992-08-05 2002-10-16 Faulding F H & Co Ltd Composicion farmaceutica peletizada.
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
US6096344A (en) * 1995-07-28 2000-08-01 Advanced Polymer Systems, Inc. Bioerodible porous compositions
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US7687542B2 (en) * 1996-05-17 2010-03-30 Kowa Pharmaeuticals America, Inc. Rapidly bioavailable tablet and capsule formulations of diclofenac
US6544556B1 (en) * 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
AR044398A1 (es) 2004-05-19 2005-09-14 Bago Sa Labor Procedimiento para la elaboracion de microcapsulas recubiertas que contienen agentes farmacologicamente activos y composiciones farmaceuticas conteniendo dichas microcapsulas".

Also Published As

Publication number Publication date
UA112345C2 (uk) 2016-08-25
MX354454B (es) 2018-03-06
SG11201505320TA (en) 2015-08-28
US9668978B2 (en) 2017-06-06
CA2899664A1 (en) 2013-09-26
WO2013139377A1 (en) 2013-09-26
EP2827843B1 (en) 2016-05-25
ES2584403T3 (es) 2016-09-27
CA2899664C (en) 2019-07-09
CL2014002465A1 (es) 2015-05-08
ZA201406886B (en) 2015-06-24
CL2016003348A1 (es) 2018-03-23
BR112014023278B1 (pt) 2021-11-16
US20170172934A1 (en) 2017-06-22
AR090187A1 (es) 2014-10-22
CN104244927A (zh) 2014-12-24
MX2014011289A (es) 2015-02-17
CN104244927B (zh) 2017-03-15
US20150072000A1 (en) 2015-03-12
PH12014501981B1 (en) 2014-11-24
PH12014501981A1 (en) 2014-11-24
EP2827843A1 (en) 2015-01-28
BR112014023278A2 (pl) 2017-06-20
US9918941B2 (en) 2018-03-20

Similar Documents

Publication Publication Date Title
EP2755826A4 (en) SYSTEM AND METHOD FOR LASER MARKING OF CAPSULES
HUE037021T2 (hu) DLL3- modulátorok és eljárások alkalmazásukra
FI20126025L (fi) Menetelmä kalsiumsilikaattihydraattipäällystettyjen partikkeleiden valmistamiseksi ja niiden käyttö
FI20105868A7 (fi) Menetelmä ja järjestelmä kalsiumkarbonaatin saostamiseksi sekä kalsiumkarbonaattia käsittävä tuote
GB201204967D0 (en) Apparatus and method of augmented reality interaction
SG11201504791VA (en) Pharmaceutical composition for treating headache, and preparation method thereof
PT2854870T (pt) Método e aparelho para a produção de chumbo 212 para uso médico¿
EP2848247A4 (en) INLGANIC NANOPARTICLE-CONTAINING INORGANIC NANOPARTICLE COMPOSITION FOR UV PROTECTION USING HYDROGEL-FORMING POLYMERS, AND PREPARATION METHOD THEREOF
ZA201406886B (en) Method for producing enteric alginate microcapsules via ionic gelation containing diflofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them
PL2844185T3 (pl) Sposób wykonywania protezy zębowej i artykulator do przeprowadzenia tego sposobu
EP2929587A4 (en) LIQUIDS, SALTS AND IONIC COMPOSITIONS BASED ON PHOSPHONIUM, METHODS OF MAKING, AND DEVICES FORMED THEREFROM
EP2820615A4 (en) SYSTEM AND METHOD FOR THE PRODUCTION OF MEDICAL REPORTS
PT2833869T (pt) Método de preparação de uma composição para administração de um fármaco aniónico
PL2822383T3 (pl) Przeciwdrobnoustrojowa kompozycja zawierająca kwas laurynowy oraz sposób jej wytwarzania
IL231505B (en) Pharmaceutical preparation and method for its production
PL2679216T3 (pl) Postać farmaceutyczna do zmodyfikowanego uwalniania betahistyny
IL239328A0 (en) A continuous process for the production of (s)-2-acetyloxypropionate chloride
IL245414A0 (en) A process for the preparation of methylphenidate and its pharmaceutical salts
IL239117A0 (en) A method for metachromatic leukodystrophy diagnosis
ZA201504691B (en) Novel veterinary pharmaceutical compositions and method for the production thereof
PL2827838T3 (pl) Kompozycja farmaceutyczna do oczu zawierająca inhibitor anhydrazy węglanowej i sposób jej wytwarzania
ZA201408723B (en) Emulsion for pharmaceutical use and method for the production thereof
PL3036218T3 (pl) Ko-kryształy agomelatyny i kwasu p-toluenosulfonowego, sposób ich wytwarzania i kompozycje farmaceutyczne je zawierające
PL398928A1 (pl) Symetryczne ciecze jonowe oraz sposób wytwarzania symetrycznych cieczy jonowych
PL398938A1 (pl) Symetryczne zwiazki heterocykliczne o charakterze cieczy jonowych oraz sposób ich wytwarzania